Teva Pharmaceutical Industries Limited (BVMF:T1EV34)
Brazil
· Delayed Price · Currency is BRL 86.94
-0.61 (-0.70%)
At close: Feb 25, 2026
BVMF:T1EV34 Ratios and Metrics
Market cap in millions BRL. Fiscal year is January - December.
Millions BRL. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Feb '26 Feb 24, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 191,160 | 197,223 | 154,662 | 56,786 | 53,548 | 49,226 | Upgrade
|
| Market Cap Growth | 74.80% | 27.52% | 172.36% | 6.05% | 8.78% | -10.37% | Upgrade
|
| Enterprise Value | 262,432 | 279,248 | 255,321 | 147,189 | 160,052 | 177,988 | Upgrade
|
| Last Close Price | 86.94 | 84.48 | 69.28 | 25.43 | 23.88 | - | Upgrade
|
| PE Ratio | 24.61 | 25.40 | - | - | - | 21.19 | Upgrade
|
| PS Ratio | 2.01 | 2.08 | 1.51 | 0.74 | 0.68 | 0.56 | Upgrade
|
| PB Ratio | 4.39 | 4.52 | 4.37 | 1.44 | 1.18 | 0.79 | Upgrade
|
| P/FCF Ratio | 30.23 | 31.19 | 33.39 | 13.90 | 9.72 | 37.44 | Upgrade
|
| P/OCF Ratio | 21.05 | 21.71 | 20.05 | 8.56 | 6.37 | 11.07 | Upgrade
|
| EV/Sales Ratio | 2.92 | 2.94 | 2.50 | 1.91 | 2.03 | 2.01 | Upgrade
|
| EV/EBITDA Ratio | 9.87 | 10.23 | 9.31 | 6.99 | 7.63 | 7.25 | Upgrade
|
| EV/EBIT Ratio | 12.70 | 12.83 | 12.24 | 9.52 | 11.37 | 10.38 | Upgrade
|
| EV/FCF Ratio | 41.50 | 44.16 | 55.12 | 36.03 | 29.06 | 135.36 | Upgrade
|
| Debt / Equity Ratio | 2.18 | 2.18 | 3.18 | 2.50 | 2.52 | 2.10 | Upgrade
|
| Debt / EBITDA Ratio | 3.39 | 3.39 | 3.98 | 4.53 | 5.26 | 5.19 | Upgrade
|
| Debt / FCF Ratio | 15.01 | 15.01 | 24.28 | 24.08 | 20.80 | 99.97 | Upgrade
|
| Net Debt / Equity Ratio | 1.73 | 1.73 | 2.60 | 2.10 | 2.19 | 1.91 | Upgrade
|
| Net Debt / EBITDA Ratio | 2.76 | 2.76 | 3.36 | 3.93 | 4.75 | 4.86 | Upgrade
|
| Net Debt / FCF Ratio | 11.91 | 11.91 | 19.87 | 20.25 | 18.11 | 90.80 | Upgrade
|
| Asset Turnover | 0.43 | 0.43 | 0.40 | 0.36 | 0.33 | 0.32 | Upgrade
|
| Inventory Turnover | 2.69 | 2.69 | 2.41 | 2.09 | 2.08 | 2.02 | Upgrade
|
| Quick Ratio | 0.54 | 0.54 | 0.50 | 0.54 | 0.57 | 0.61 | Upgrade
|
| Current Ratio | 1.04 | 1.04 | 0.98 | 1.02 | 1.05 | 1.14 | Upgrade
|
| Return on Equity (ROE) | 20.79% | 20.79% | -28.30% | -7.36% | -25.19% | 4.09% | Upgrade
|
| Return on Assets (ROA) | 6.17% | 6.17% | 5.09% | 4.55% | 3.63% | 3.91% | Upgrade
|
| Return on Invested Capital (ROIC) | 18.07% | 18.73% | 14.74% | 12.10% | 8.85% | 6.18% | Upgrade
|
| Return on Capital Employed (ROCE) | 14.50% | 14.50% | 12.70% | 10.20% | 8.20% | 8.40% | Upgrade
|
| Earnings Yield | 4.06% | 3.94% | -6.55% | -4.78% | -24.15% | 4.72% | Upgrade
|
| FCF Yield | 3.31% | 3.21% | 3.00% | 7.20% | 10.29% | 2.67% | Upgrade
|
| Buyback Yield / Dilution | -2.83% | -2.83% | -1.07% | -0.81% | -0.27% | -1.10% | Upgrade
|
| Total Shareholder Return | -2.83% | -2.83% | -1.07% | -0.81% | -0.27% | -1.10% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.